Menu Fermer

Articles sur Johnson & Johnson

Ensemble des articles

Public health officials have been waiting for good data before making any decisions about booster shots for people who received Johnson & Johnson’s Janssen COVID-19 vaccine. AP Photo/Mary Altaffer

New Johnson & Johnson data shows second shot boosts antibodies and protection against COVID-19 – but one dose is still strong against delta variant

Your body produces antibodies after an infection or vaccine, but these slowly decline over time. New Johnson & Johnson data sheds light on the duration of protection and the need for booster shots.
Photo by Sharon Seretlo/Gallo Images via Getty Images

South Africa’s vaccine quagmire, and what needs to be done now

South Africa has clearly suffered the consequences of poor strategic decisions to this point. It doesn’t need to continue along these lines.
Though drug recalls are relatively uncommon in the U.S., reduced inspections increase the likelihood of manufacturing errors that slip through the cracks. AP Photo/Rafiq Maqbool

The FDA’s weak drug manufacturing oversight is a potentially deadly problem

COVID-19 has exacerbated a backlog of domestic and foreign drug manufacturing inspections that the FDA is still too short-staffed to adequately deal with.
The concern is about more than one shot vs. two. Michael Ciaglo/Getty Images

Backlash against Johnson & Johnson’s COVID-19 vaccine is real and risky – here’s how to make its rollout a success

Religious opposition over a link to abortions performed decades ago and misunderstandings about effectiveness could lead to a nightmare of angry patients and wasted vaccine.
The pharmaceutical industry opposes the suspension of intellectual property rights on COVID-19 vaccines and treatments, and no pharma companies have yet contributed to the COVID-19 Technology Access Pool. (Shutterstock)

Can a pharma company change? Profit, not altruism, motivates COVID-19 vaccine development

We should applaud drug companies for developing COVID-19 vaccines in record time, but let’s not be under any illusion about the profits that are motivating them.
Johnson & Johnson was ordered to pay US$.4.69 billion in July, 2018 because it failed to warn customers that its baby powder contains asbestos. Matt Rourke/AP Photo

Why asbestos litigation won’t go away: Because asbestos won’t go away

Asbestos litigation is the number one source of tort claims in the US, with many people decrying the filing of so many claims. But there’s a reason the claims persist. Asbestos isn’t going anywhere.
Ron Barnes, Doug Cope, Eileen Webber and Bob Lugton feature in ABC TV’s 4 Corners documentary The Walking Wounded. The Walking Wounded, Four Corners

The Walking Wounded calls for a rethink of what we most value

Starting with Karl Marx, many thinkers have pointed out that the creative potential of the capitalist economic system comes at a cost – the lack of inherent ethical scruples to limit the inexorable logic…

Les contributeurs les plus fréquents

Plus